Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Berhanu Geresu Kibret, Hiroki Ishiguro, Yasue Horiuchi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 975-975
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

CB2 receptor in the CNS: From immune and neuronal modulation to behavior
Wanda Grabon, Sylvain Rheims, Jonathon Smith, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 150, pp. 105226-105226
Open Access | Times Cited: 26
Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
Maria de Fátima dos Santos Sampaio, Yara Bezerra de Paiva, Tuane Bazanella Sampaio, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 5, pp. 574-601
Open Access | Times Cited: 8
Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
Ana Tadijan, Ignacija Vlašić, Josipa Vlainić, et al.
Antioxidants (2022) Vol. 11, Iss. 10, pp. 2049-2049
Open Access | Times Cited: 35
Cannabinoid receptor 2 plays a key role in renal fibrosis through inhibiting lipid metabolism in renal tubular cells
Shan Zhou, Xian Ling, Ye Liang, et al.
Metabolism (2024) Vol. 159, pp. 155978-155978
Open Access | Times Cited: 6
A Proteomic Approach Identified TFEB as a Key Player in the Protective Action of Novel CB2R Bitopic Ligand FD22a against the Deleterious Effects Induced by β-Amyloid in Glial Cells
Beatrice Polini, Lorenzo Zallocco, Francesca Gado, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 875-875
Open Access | Times Cited: 5
Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela Carmen Ababei, et al.
Biology (2022) Vol. 11, Iss. 3, pp. 440-440
Open Access | Times Cited: 23
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
Hiroki Ishiguro, Berhanu Geresu Kibret, Yasue Horiuchi, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 20
Update on the controversial identity of cells expressing cnr2 gene in the nervous system
Wanda Grabon, Jacques Bodennec, Sylvain Rheims, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 3, pp. 760-770
Open Access | Times Cited: 10
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Hina Kanwal, Moris Sangineto, Martina Ciarnelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4050-4050
Open Access | Times Cited: 3
Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery
Mendhi Henna Dasram, Roderick B. Walker, Sandile M. Khamanga
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13223-13223
Open Access | Times Cited: 16
Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation
Hong Zhu, Feng Xiao, Yao Xiao, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 9
In silico analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution
Amy L. Cherry, Michael Wheeler, Karolina Mathisova, et al.
Frontiers in Neuroinformatics (2024) Vol. 18
Open Access | Times Cited: 2
The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics
HeeJue Hong, Lucy Sloan, Deepak Saxena, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1959-1959
Open Access | Times Cited: 12
Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety
Wenjiao Yang, Xudong Gong, Haiguo Sun, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116048-116048
Closed Access | Times Cited: 7
Relationship between the therapeutic potential of various plant-derived bioactive compounds and their related microRNAs in neurological disorders
Xiaoyu Dong, Jianfei Nao
Phytomedicine (2022) Vol. 108, pp. 154501-154501
Closed Access | Times Cited: 11
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
Barbara Vuić, Tina Milos, Lucija Tudor, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3000-3000
Open Access | Times Cited: 11
Cannabigerol modulates α2-adrenoceptor and 5-HT1A receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat
Aitziber Mendiguren, Erik Aostri, Irati Rodilla, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges
Hannah R. Wardill, Luke T. Wooley, Olivia M. Bellas, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 1, pp. 19-30
Open Access | Times Cited: 5
The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies
Wujood Khayat, Christine Lehmann
Metabolites (2022) Vol. 12, Iss. 6, pp. 541-541
Open Access | Times Cited: 9
Electrophysiological Phenotypes of Hippocampal Synaptic and Network Functions in Cannabinoid Receptor 2 Knockout Mice
Shuangtao Li, Yong‐Chang He, Dharshaun Turner, et al.
Cannabis and Cannabinoid Research (2024) Vol. 9, Iss. 5, pp. 1267-1276
Closed Access | Times Cited: 1
Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality
A.J. Carrascosa, Francisco Navarrete, Raquel Saldaña, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6268-6268
Open Access | Times Cited: 1
Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs
Hong-Qing Zhao, Yang Liu, Na Cai, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2143-2167
Open Access | Times Cited: 1
PET imaging of neuroinflammation: any credible alternatives to TSPO yet?
Fabien Chauveau, Alexandra Winkeler, Sylvie Chalon, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 1
The cannabinoid CB 2 receptor positive allosteric modulator EC21a exhibits complicated pharmacology in vitro
Aidong Qi, Xueqing Han, Marc Quitalig, et al.
Journal of Receptors and Signal Transduction (2024), pp. 1-9
Closed Access | Times Cited: 1
The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
Ivona Maria Tudorancea, Mitică Ciorpac, Gabriela Dumitrița Stanciu, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2492-2492
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top